
FDA Approves 12.5 mg Chlorthalidone Tablets for Hypertension
The US Food and Drug Administration (FDA) has approved 12.5 mg chlorthalidone tablets (HemiClor), targeted to lower blood pressure in the treatment of adults with hypertension.1 Announced by PRM Pharma, LLC, on May 6, 2025, 12.5 mg chlorthalidone tablets …